SCHEMBL13319673

SCHEMBL13319673

Cc1cccc(-c2c3ccc(-n4c5ccccc5c5ccccc54)cc3c(-c3cccc(C)c3)c3ccc(-n4c5ccccc5c5ccccc54)cc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
RXFP1 Q9HBX9 1/20 0.39
HPGD P15428 1/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
NR3C1 P04150 1/20 0.36
TP53 P04637 2/20 0.35
MAPK14 Q16539 1/20 0.35
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428004 0.91 NR3C1 (0.39) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL10098605 0.91 L3MBTL1 (0.47) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL13428055 0.90 MCL1 (0.36) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL4546831 0.90 L3MBTL1 (0.46) L3MBTL1KDM4EATMRXFP1HPGD
SCHEMBL9914765 0.88 KDM4E (0.44) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL13427915 0.88 KDM4E (0.43) L3MBTL1KDM4EATMRXFP1HPGD
SCHEMBL26214671 0.85 L3MBTL1 (0.44) L3MBTL1KDM4EATMRXFP1HPGD
SCHEMBL11910863 0.85 KDM4E (0.37) L3MBTL1KDM4EATMRXFP1HPGD
SCHEMBL11910844 0.85 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL13319690 0.85 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME CRY1, CRY2, CYBA L3MBTL1 146/4885KDM4E 3622/4885ATM 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.